Wed 08/04/2021 17:44 PM
Investors, or limited partners, in Novalpina have extended the date by which the company expects to make a final decision on the fate of the €1 billion private equity fund, which owns Israeli spyware company NSO Group, Estonian casino group Olympic Entertainment and French specialty pharma company Laboratoire X.O, to Aug. 27, according to sources close to the matter. Novalpina’s investors had lined up Berkeley Research Group, or BRG, to manage the fund and were initially expected to finalize...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.